San Diego, CA, United States of America

Mark Renshaw

USPTO Granted Patents = 9 

 

 

Average Co-Inventor Count = 3.4

ph-index = 4

Forward Citations = 168(Granted Patents)


Company Filing History:


Years Active: 2007-2024

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Mark Renshaw: Innovator in Biopharmaceuticals

Introduction

Mark Renshaw is a prominent inventor based in San Diego, CA, known for his significant contributions to the field of biopharmaceuticals. He holds a total of 9 patents, showcasing his innovative approach to addressing complex medical challenges. His work primarily focuses on developing therapeutic solutions for autoimmune diseases and enhancing detection methods for vital analytes.

Latest Patents

Among his latest patents is the development of anti-CD30L antibodies and their pharmaceutical compositions aimed at treating autoimmune diseases such as inflammatory bowel disease (IBD), including Crohn's Disease (CD) and ulcerative colitis (UC). This groundbreaking work has the potential to transform treatment options for patients suffering from these debilitating conditions. Another notable patent involves a processing reagent and its application in assays for detecting analytes associated with binding proteins. This method allows for the separation of analytes, such as vitamin D, from their associated proteins, facilitating more accurate detection in blood samples.

Career Highlights

Mark Renshaw has worked with leading companies in the biopharmaceutical sector, including Alexion Pharmaceuticals, Inc. and Prometheus Biosciences, Inc. His experience in these organizations has contributed to his expertise in developing innovative solutions for complex health issues.

Collaborations

Throughout his career, Mark has collaborated with talented professionals, including Shana Frederickson and Katherine S Bowdish. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Mark Renshaw's contributions to the field of biopharmaceuticals through his patents and collaborations highlight his role as a key innovator. His work continues to pave the way for advancements in the treatment of autoimmune diseases and the detection of critical health markers.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…